# A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis

> **NCT07136805** · PHASE3 · NOT_YET_RECRUITING · sponsor: **VivaVision Biotech, Inc** · enrollment: 152 (estimated)

## Conditions studied

- Non-infectious Anterior Uveitis

## Interventions

- **DRUG:** VVN461 Ophthalmic Solution 1.0%
- **DRUG:** 1.0% prednisolone acetate

## Key facts

- **NCT ID:** NCT07136805
- **Lead sponsor:** VivaVision Biotech, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-04-30
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07136805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07136805, "A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07136805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*